Lighthouse Pharmaceuticals, Inc.

Novato, CA

UEI
PD46PCMTRUM6
CAGE
9P3X9
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
8001 Redwood Blvd, Novato, CA 94945, USA
Website
lighthousepharma.com
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
87 Engineering & Management Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Lighthouse Pharmaceuticals, Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
A randomized, double-blind, placebo-controlled study of LHP588 in subjects with p. Gingivalis-positive alzheimer's… Grant · R01AG088524 National Institute on Aging $50,367,808

Quick answers

What is Lighthouse Pharmaceuticals, Inc.'s UEI?

Lighthouse Pharmaceuticals, Inc.'s Unique Entity ID (UEI) in SAM.gov is PD46PCMTRUM6.

What is Lighthouse Pharmaceuticals, Inc.'s CAGE code?

Lighthouse Pharmaceuticals, Inc.'s CAGE code is 9P3X9.

What is Lighthouse Pharmaceuticals, Inc.'s primary NAICS code?

Lighthouse Pharmaceuticals, Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Lighthouse Pharmaceuticals, Inc. located?

Lighthouse Pharmaceuticals, Inc.'s physical address in SAM.gov is 8001 Redwood Blvd, Novato, CA 94945, USA.

Is Lighthouse Pharmaceuticals, Inc. registered in SAM.gov?

Yes. Lighthouse Pharmaceuticals, Inc.'s SAM.gov registration is active through May 15, 2027.

What is Lighthouse Pharmaceuticals, Inc.'s most recent federal award?

Lighthouse Pharmaceuticals, Inc.'s most recent federal grant award is A randomized, double-blind, placebo-controlled study of LHP588 in subjects with p. Gingivalis-positive alzheimer's… (R01AG088524), from National Institute on Aging, on August 15, 2025.

On GovTribe

See Lighthouse Pharmaceuticals, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login